REQUEST A DEMO
Total
USD $0.00
Search more companies

Precision Biosensor Inc. (South Korea)

Main Activities: Electromedical and Electrotherapeutic Apparatus Manufacturing
Full name: Precision Biosensor Inc. Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Company is a Korea-based company mainly engaged in the development, manufacture and sale of in vitro diagnostic reagents. The Company s main products include testers and cartridges. The testers are portable immunoassay diagnostic devices for on-site diagnosis that uses colorimetric and time-resolved fluorescence to check acute heart disease, metabolism, and inflammatory diseases. The cartridges are used in gold absorption and time-resolved fluorescence analysis diagnostic equipment, and can check acute heart disease, metabolism, and inflammatory diseases. The Company was established on September 28, 2009. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on December 22, 2020.

Headquarters
306, Techno 2-Ro, Yuseong-Gu
Daejeon; Daejeon;

Contact Details: Purchase the Precision Biosensor Inc. report to view the information.

Website: http://precision-bio.com

Basic Information
Total Employees:
Purchase the Precision Biosensor Inc. report to view the information.
Outstanding Shares:
Purchase the Precision Biosensor Inc. report to view the information.
Registered Capital:
Purchase the Precision Biosensor Inc. report to view the information.
Financial Auditors:
Purchase the Precision Biosensor Inc. report to view the information.
Incorporation Date:
September 28, 2009
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Subsidiaries
Nano-Ditech Co., Ltd
Company Performance
Financial values in the chart are available after Precision Biosensor Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-0.33%
Total operating revenue
0.62%
Operating profit (EBIT)
-0.67%
EBITDA
38.82%
Net Profit (Loss) for the Period
34.02%
Total assets
5.88%
Total equity
-4.04%
Operating Profit Margin (ROS)
-0.21%
Net Profit Margin
11.25%
Return on Equity (ROE)
6.37%
Debt to Equity Ratio
13.78%
Quick Ratio
0.13%
Cash Ratio
-0.2%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?